Alnylam Pharmaceuticals, Inc.
Compositions and methods for inhibiting expression of the LECT2 gene

Abstract:

The invention relates to antisense polynucleotide agents targeting the LECT2 gene, and methods of using such antisense polynucleotide agents to inhibit expression of LECT2 and to treat subjects having a LECT2-associated disease, e.g., amyloidosis.